As noted previously, the Oklahoma Medical Research Foundation is in the process of auditing and building a data base of key success cases. But it gets more exciting.
A man who is taking the protocol from this blog sent me the attached article which corroborates my own previous knowledge and research as to “Why fenbendazole appears to be cancer agnostic in its efficacy. He sent this to an old college friend who is a cancer cell biologist at a major University.
The Indian research paper linked above (that hardly anyone takes the time to download and read which is a real shame) tells me that the regimen is not only cancer agnostic, but also an effective prophylactic regimen.
I have had many people ask gazillions of questions surrounding the confusion around my recommendation to take 25mg of CBD per day. Let me attempt to clear things up a bit, at least from my perspective.
I think it is time to discuss and deal with the growing concern that 222mg of Fenbendazole could seriously damage the liver. This concern seems to take on a life of its own as non-scientists try to decipher anything and everything they seem to find on the internet.
As I promised earlier and have almost been “a broken record” that we would start a major project of auditing all of the use cases that we know about thus far. The major research foundation was forced to wait until the available scientists freed up for the project, as well as awaiting funding.
Without boring you with the details, the following paper was recently issued by Stanford University and University of Washington. The significance? All clinicians, scientists AND patients come from the project we started at the Oklahoma Medical Research Foundation to begin auditing success stories.